Preclinical Imaging and Animal Models – Clinical Translation on ovarian cancer

Technical leader: partner organization CHUV (CH) Preclinical Imaging and Animal Models – Clinical Translation on ovarian cancer Objective: Develop translational imaging and therapy with monoclonal antibodies for ovarian cancer Expected Results: The ESR will be in charge of performing the translation from a successful preclinical model for diagnosis to a first study in humans, firstly from a diagnostic point of view, and secondarily, as a preclinical therapeutic radioimmunotherapy and then, if feasible into a therapy in humans; His supervisor, Dr. Melita Irving, (Ludwig Center for Cancer Research, University of Lausanne, Biopôle III ) will train him performing molecular biology and preclinical antibody research on ovarian cancer in mice. At CHUV, preclinical imaging will be done in nuclear medicine with μPET/SPECT/CT, and for clinical trials, PET/CT and SPECT/CT clinical scanners and radiation shielded beds for clinical therapy.